Archer Materials shares climb as quantum partnership advances, but qubit demonstration delayed
AXE: $0.170 -2.86% · MC: $47M
Archer Materials shares climbed nearly 6% to about 19 cents at 10:25 am after the company reported progress on its IonQ partnership and biosensor program, while acknowledging a delay to its quantum hardware demonstration.
The company said it had deepened its partnership with IonQ and launched a commercial pilot inviting Australian enterprises to submit computational problems for testing on IonQ hardware. Its fraud detection collaboration with CSIRO remains on track to produce benchmark demonstration data by the middle of FY27.
Archer said development of its biosensor beta prototype had progressed towards external testing, and commercial discussions had advanced with a US clinical research institution. A structured trial is targeted for the final quarter of FY27. The functional graphene qubit demonstration is taking longer than anticipated because of technical challenges; Archer said it remains focused on delivering a functional qubit with readout during FY27.

Comments